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increasingly to impact later life. Epidemiologic studies document an association between expo-
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timing of menarche, and risk for hypertension or breast cancer.
Methods: This article brieﬂy reviews the concept of windows of susceptibility for providers who
care for adolescent patients.
Results: The theoretical bases for windows of susceptibility is examined, evaluating the rela-
tionship between pubertal change and breast cancer as a paradigm, and reviewing the underlying
mechanisms, such as epigenetic modiﬁcation.
Conclusions: The long-term sequela of responses to early exposures may impact other adult
morbidities; addressing these exposures represents an important challenge for contemporary
medicine.
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This article provides an
introduction for the
concept of windows of
susceptibility for health
care providers with adoles-
cent patients. It examines
thedevelopmentalbasis for
associating early life expo-
sures with adult disorder-
susing the paradigms of
pubertal change and breast
cancer and of biobehavioral
susceptibility to environ-
mental inﬂuences.Over the past several decades, there has been an increasing
awareness that early life events may shape developmental
trajectories and thereby impact later health [1]. For example,
adult diseases, such as breast cancer and ischemic heart disease,
are believed to have origins in the early stages of life, and in
recent years the study of breast cancer etiology has moved
toward studying events during childhood [2]. Adolescence hasreceived little attention, despite the important behavioral,
cognitive, and physical developmental changes that occur during
this period. In this rapidly evolving area of study, several
frameworks have been forwarded to explain these ﬁndings,
incorporating diverse disciplines and perspectives that impact
physical and mental health issues at the individual as well as
public health level. These models are not mutually exclusive, yet
often emphasize a speciﬁc perspective on antecedents or
outcomes. This article will review brieﬂy the literature that
explores the factors in early life that impact the physiologic
changes associated with puberty and how these inﬂuence adult
morbidity using breast cancer as a paradigm.
Birth weight perhaps has been the most studied early life
factor impacting later health. Both lower and higher birthweight,
comparedwithnormal, appear tohave implications for short- and
long-term outcomes across the life course. The impact of fetal
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vations of three cohortsdchildren born during the Dutch famine
of 1944, bornwithin the Hertfordshire (UK) district between 1911
and 1930, and selected from the Helsinki Birth Cohort of
1934e44dhave led researchers to note the association between
small size at birth and during infancy and later increased
morbidity and mortality. The increased rates of adverse health
outcomes included those for coronary heart disease [3e7]; stroke
[7,8]; insulin resistance [9]; and type 2 diabetes mellitus [10];
adiposity [11,12], especially visceral fat distribution [13]; meta-
bolic syndrome (associated with both low birth weight and
maternal obesity [14]; and osteoporosis [15]. The increased rates
led some early researchers tohypothesize the “thrifty phenotype”
[10], often called the “Barker hypothesis,” as described below.
Nutritional excess during pregnancy has also been linked to
adverse outcomes from childhood through adulthood, especially
for development of obesity and type 2 diabetes [16]. Studies
found that maternal triglyceride levels were associated with
newbornweight [17] and that the strongest prenatal predictor of
pediatric overweight and adiposity is maternal body mass index
(BMI) [18]. Studies also found positive associations between birth
size and cord insulin-like growth factor (IGF)-1 levels [19,20], as
well as cord leptin levels [20], and between birth weight with
adolescent height and lower age of menarche [21,22].
Developmental Plasticity
Observations of the association between higher infant death
rates and adult coronaryartery disease in contemporary peerswho
survived infancy [23] and between infant birthweights and insulin
resistance [10] led Barker and colleagues to develop the “thrifty
phenotype” hypothesis. That is, the prenatal environment has
limited nutritional resources andwould lead tometabolic changes,
such as insulin resistance, enhanced energy storage, and decreased
nephron number, to enhance postnatal success in an anticipated
energy-limited environment. However, the infant encounters an
imbalance that occurs between the prenatal and postnatal envi-
ronment,with sufﬁcient or even excess caloric exposure, leading to
adverse consequences. This is described as a “programmed” effect
that results from a permanent or long-term change in structure or
function throughmetabolic imprinting and/or epigenetic changes,
acting at critical period of early life. This concept was incorporated
into developmental plasticity, deﬁned as variations in develop-
mental pathways that are triggered by environmental events
during sensitive periods in development [24], which others call
critical windows of sensitivity [25] (or windows of susceptibility).
Thesewindows typicallyoccurduringperiods of rapidgrowth [25].
Several different models have been proposed to explain these
ﬁndings. The theoretical frameworks include, amongothers, thrifty
genotype [26] as well as thrifty phenotype [10]; developmental
plasticity [24]; ecobiodevelopmental framework [27]; life history
theory [28]; adaptive calibration model; and developmental
origins of adult disease [29]. A similar perspective is the predictive
adaptive response, which is a response to an environmental factor
that may not be of immediate beneﬁt but made in expectation of
a future environment [30]; environment could include not only in
utero factors, but also postnatal psychosocial, nutritional, or
chemical exposures. These responses carry costs, as suggested by
lifehistory theory [28,31]; increasedallocationof resources tobrain
growth or energy storage would reduce resources for other traits,
such as tissue repair processes. These adaptations are considered
the basis of the adverse consequences of fetal undernutrition andmaternal overnutrition, leading to the fetal origins of adult disease
[32]. As discussed later, the adaptations in structure and function
are long-term or permanent, and there is increasing evidence that
epigenetic mechanisms may be responsible, prompting some to
suggest that, rather than a thrifty genotype [26] or thrifty pheno-
type [10], the underlying mechanism is the thrifty epigenotype,
incorporating both hypotheses through proposing epigenetic
variations to enhance energy storage and utilization [33]. These
hypotheses resulted in a renewed interest in exposures that occur
at periods of increased susceptibility, such as during fetal devel-
opment and puberty. For example, Barker noted the relationship
betweensmall-for-gestational-age statusandgreaterprevalenceof
adult hypertension [4]. Brenner suggested that small-for-
gestational-age status may be associated with decreased nephron
number [34]andsubsequent riskofhypertension.Zendi-Nejadand
colleagues reviewed the role of fetal programming on adult
hypertension and kidney disease and suggested several explana-
tions, including epigenetic changes, increased apoptosis in the fetal
kidney, increased exposure to fetal glucocorticoids, and alterations
in the renin-angiotensin system [35].
Pubertal Milestones and Relative Timing of Puberty
Puberty represents an important developmental window of
vulnerability to environmental exposures. Puberty is a time of
rapid and profound change, including (re)activation of the
hypothalamic-pituitary-gonadal and hypothalamic-pituitary-
adrenal axes, an acceleration in height velocity and achieve-
ment of the pubertal peak height velocity, changes in body
composition, the development of secondary sexual characteris-
tics, and the achievement of fertility. The temporal relationships
between these events are shown in Figure 1, and compared with
timing of breast development. During puberty, there is rapid
expansion and differentiation of breast stem cells, as discussed
later, which occurs contemporaneously with reactivation of the
hypothalamic-pituitary-ovarian axis, the onset of the pubertal
growth spurt, and the time of maximal accrual of bone mineral
content. The temporal relationships between these factors may
suggest shared or underlying biologic mechanisms.
The timing of puberty may serve as a sensitive indicator of
environmental change [36]. There is a 4-year variability in onsetof
puberty in girls [37]. It is estimated that 61% to75%of the variation
in age at menarche, which is correlated to onset of puberty, is
attributable to direct or additive genetic effects [38,39]. Recent
reviews reported that there are 42 loci associated with timing of
puberty but noted that these loci make a small contribution
(3.6%e6.1%) to the variability of age at onset [40,41]. Greater BMI
during childhood is associated with earlier age at menarche
[42,43]; this association may be related to greater levels of leptin
reﬂecting sufﬁcient energy stores [44] or other mechanisms
associated with visceral adiposity [45,46]. Parent et al. reviewed
other factors that could impact variability in timing of puberty:
they include genetic factors and intrauterine environment, as
noted previously; nutritional intake; climatic exposures; light-
dark cycle; and exposure to endocrine-disrupting chemicals [47].
Psychosocial Factors and Puberty
In addition to metabolic and biologic exposures, studies have
linked timing of puberty in girls to adversity in the psychosocial
realm. Consistent with evolutionary life history theory, Belsky
and colleagues [48] posited that when girls encountered
Figure 1. Pubertal milestones and breast development.
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mental stressors), it was generally adaptive for them to become
reproductively mature at earlier ages [48]. Empirical evidence
has conﬁrmed that childhood adversity accelerates girls’
pubertal development [49]. In countries that have adequate
nutrition, such as the United States, lower socioeconomic status
has been associated with earlier menarche, although effects may
vary depending on race/ethnicity [50]. In addition, harsh-
conﬂictual family dynamics and poor parent-child attachment
predict earlier maturation, whereas warm and supportive family
conditions forecast later puberty among girls [51e54]. The
absence of a biological father also has been associated with
earlier pubertal timing, such that girls with no father in the home
prepubertally are about twice as likely to experience menarche
earlier than age 12 years than those with a father present
[52,54e58]. Studies of stepfathers have yielded inconsistent
ﬁndings, and there is no evidence to suggest that a mother’s
absence inﬂuences puberty; however, the presence of siblings
may play a role in delaying menarche [55,59].
The role that prepubertal BMI may play in mediating associ-
ations between adverse family factors and girls’ pubertal devel-
opment is somewhat unclear. Some studies suggest that the
inﬂuence of father absence on girls’ pubertal development is
mediated by BMI [60], whereas other studies do not note BMI as
a mediator [56,61]. Future research is needed to further explore
whether BMI or other measures of body composition (e.g.,
visceral adiposity) may help explain associations between
adverse family factors and girls’ pubertal timing.
Pubertal Events and Breast Cancer
Recently, attention has been turned toward the associations
between early life events, pubertal changes, and risk for breastcancer in adulthood. Although exposures across the life span
have been linked to breast cancer risk [2], the mechanisms
underlying the relationship remain unclear. During puberty,
mammary growth occurs through exponential cellular prolifer-
ation and differentiation, suggesting a stem-like cell with
regenerative capacity [62], and the mammary gland undergoes
extensive changes. Primary ducts grow and divide with forma-
tion of terminal end buds, which further divide into smaller
alveolar buds and form the lobule type 1 unit. There is additional
growth and differentiation into lobules 2 and 3 throughout
puberty and into adulthood (Figure 1). Of note, breast epithelium
exhibits maximal proliferative activity during the luteal phase of
the menstrual cycle, and the highest level of cell proliferation is
observed in undifferentiated lobule type 1 [63]. Full differentia-
tion into lobule type 4 occurs as a result of pregnancy, with
permanent alterations in gene expression pattern. These
pregnancy-associated changes have been hypothesized to result
in cells that are more refractory to environmental exposures
[64,65], unlike the earlier progenitor cells that are believed to be
the cellular target for potential carcinogens and is proposed as
the mechanism underlying decreased risk for breast cancer with
earlier age at ﬁrst full-term pregnancy [66]. For example, local
girls 19 years or younger when the Nagasaki and Hiroshima atom
bombs were dropped were more likely than local adults to
develop breast cancer [67], suggesting an increased susceptibility
for younger women to the effects of radiation.
There are several epidemiologic associations between
pubertal events and risk of breast cancer, including age of
menarche, growth factors (height and height velocity), and bone
mineral density. Epidemiologic studies support up to 30%
increased risk with younger age at menarche [2,68e72]. A pooled
analysis reported that for each year that age of menarche was
delayed, the risk of premenopausal breast cancer was reduced by
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[68]. Menarche is one of the most well-established risk factors
for breast cancer, in part because the age at which menarche
occurred can be recalled years later [73]. Young age at onset of
menarche is associated with young age at onset of breast
development and with young age during the pubertal growth
spurt. Young age during the pubertal growth spurt is associated
with greater growth velocity [74]. Of note, obese and tall children
have greater levels of IGF-1 in response to growth hormone than
do short and normal-weight children [75], and IGF-1 may
mediate the relationship betweenmenarche and breast cancer. A
recent study noted that the age at menarche was associated with
risk of breast cancer, but not when age at peak growth was
included in the analysis: this study found that risk for breast
cancer increased 11% for every 5-cm increase in adult height [76].
Similarly, if a woman reached her maximum height at or before
age 12 years, her risk of breast cancer increased by 1.4 [77].
Several studies documented the relationship between greater
bone mineral density and later development of breast cancer
[78e82]. Of note, the majority of bone mineral content is
deposited during the teenage years, peaking shortly after the age
at peak height velocity [83].
With regard to the concept of “windows of susceptibility,”
important factors may expand the window or lead to more
intense exposures. For example, early maturation leads to longer
duration of puberty and to a greater peak height velocity. That is,
early age at onset of puberty is associated with longer interval
between onset of puberty and menarche [84e86] and therefore
longer time for completion of puberty [84], with an increased
risk for perturbation during cell proliferation and differentiation.
Similarly, early age at onset of puberty is associated with greater
height velocity (and IGF-1 levels) [84,87]; and greater IGF-1
levels are associated with greater premenopausal breast
density [88,89], another factor associated with risk of breast
cancer. In addition, the risk of breast cancer (and several other
cancers) increases with greater height [90], with a 1.17 increased
risk for every 10 cm of adult height. As noted earlier, greater BMI
is associated with earlier maturation in girls, and earlier matu-
ration is associatedwith higher BMI and increased risk of obesity.
An analysis from the Bogalusa Heart Study found that greater
childhood BMI was associated with earlier pubertal onset, and
earlier puberty with greater BMI as an adult, but the relationship
suggested that childhood BMI was the major factor [91]. A recent
review suggests how IGF-1 might impact risk of cancer [89]: the
action of IGF-I promotes tumor growth and mitosis, inhibits
apoptosis, and induces endothelial growth factor. Multiple
reviews discuss the association of obesity and several different
cancers [92], and as well as the underlying mechanisms for this
association, which include pro-inﬂammatory cytokines [93].
It is important to consider a life course approach in the care of
the adolescent. There is limited evidence, however, for inter-
ventions to decrease risk of later breast cancer in children and
adolescents. Multiple studies have documented an increased risk
of breast cancer with exposure to ionizing radiation during
childhood and adolescence, both from survivors of nuclear
bombs [94], as well as lower dose exposures [95], including serial
radiographs for scoliosis, especially with a family history of
breast cancer [96]. These studies would suggest that minimizing
children and adolescents to ionizing radiation exposurewould be
beneﬁcial. Another potential exposure is alcohol; in a review of
dietary factors and breast cancer, alcohol was the only consistent
factor associated with increased risk [97], perhaps mediatedthrough the association of alcohol with increased breast density.
Although the literature is somewhat inconsistent, soy intakemay
be beneﬁcial, with some studies citing intake during childhood
[98] or during adulthood [99]. Physical activity levels may also be
protective, and a case-control study noted that physical activity
at ages 14 to 20 years decreased risk of breast cancer [100]. The
relationship between hormonal contraceptives and breast cancer
is controversial, although risk in younger users with BRCA1 and
BRCA2 mutations may be increased modestly [101].
This article provides a brief review of a rapidly evolving ﬁeld of
inquiry, the developmental basis of adult disease, with an
emphasis on the concepts of developmental plasticity and
windows of susceptibility. We have focused on one adult disease,
breast cancer, to discuss how changes during puberty may be
particularly important for later disease. This is especially relevant
for health providers of adolescents, who are familiar with a life
course model of health, but may be unaware of studies from early
life research or on adult outcomes. Early life factors may impact
pubertal changes and predisposition to speciﬁc adult morbidities
and mortality. The long-term changes may be mediated through
epigenetic changes, as well as or resulting in, structural and
functional changes to organs and body systems, and are imple-
mentedby thedevelopingorganismtoenhancesurvival. The long-
term sequela of these responses to early exposures may apply to
several other adult morbidities and addressing these exposures
represent an important challenge for contemporary medicine.References
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